Order Article Reprints

Fujishima Y, Nishizawa H, Kawachi Y, Nakamura T, Akari S, Ono Y, Fukuda S, Kita S, Maeda N, Hoshide S, et al. The Effects of Topiroxostat, a Selective Xanthine Oxidoreductase Inhibitor, on Arterial Stiffness in Hyperuricemic Patients with Liver Dysfunction: A Sub-Analysis of the BEYOND-UA Study. Biomedicines. 2023; 11(3):674. https://doi.org/10.3390/biomedicines11030674

Fujishima, Yuya, Hitoshi Nishizawa, Yusuke Kawachi, Takashi Nakamura, Seigo Akari, Yoshiyuki Ono, Shiro Fukuda, Shunbun Kita, Norikazu Maeda, Satoshi Hoshide, and et al. 2023. "The Effects of Topiroxostat, a Selective Xanthine Oxidoreductase Inhibitor, on Arterial Stiffness in Hyperuricemic Patients with Liver Dysfunction: A Sub-Analysis of the BEYOND-UA Study" Biomedicines 11, no. 3: 674. https://doi.org/10.3390/biomedicines11030674

Fujishima, Y., Nishizawa, H., Kawachi, Y., Nakamura, T., Akari, S., Ono, Y., Fukuda, S., Kita, S., Maeda, N., Hoshide, S., Shimomura, I., & Kario, K. (2023). The Effects of Topiroxostat, a Selective Xanthine Oxidoreductase Inhibitor, on Arterial Stiffness in Hyperuricemic Patients with Liver Dysfunction: A Sub-Analysis of the BEYOND-UA Study. Biomedicines, 11(3), 674. https://doi.org/10.3390/biomedicines11030674